Target
Platelet-activating factor receptor
Ligand
BDBM50282041
Substrate
n/a
Meas. Tech.
ChEBML_155135
IC50
900±n/a nM
Citation
 Wood, LWhittaker, MTimmis, DJThompson, TMSaroglou, LMiller, ADavidson, AHChristodoulou, MSCackett, KSBowles, SABebbington, DS Cyclic ether acetal platelet activating factor (PAF) receptor antagonists II: imidazo[4,5-c]pyridyl derivatives Bioorg Med Chem Lett 3:1499-1504 (1993)    Article 
Target
Name:
Platelet-activating factor receptor
Synonyms:
PAF Platelet activating factor | PAF-R | PAFR | PTAFR | PTAFR_HUMAN | Platelet activating factor receptor | Platelet-activating factor receptor
Type:
Enzyme Catalytic Domain
Mol. Mass.:
39219.60
Organism:
Homo sapiens (Human)
Description:
PAF Platelet activating factor PTAFR HUMAN::P25105
Residue:
342
Sequence:
MEPHDSSHMDSEFRYTLFPIVYSIIFVLGVIANGYVLWVFARLYPCKKFNEIKIFMVNLTMADMLFLITLPLWIVYYQNQGNWILPKFLCNVAGCLFFINTYCSVAFLGVITYNRFQAVTRPIKTAQANTRKRGISLSLVIWVAIVGAASYFLILDSTNTVPDSAGSGNVTRCFEHYEKGSVPVLIIHIFIVFSFFLVFLIILFCNLVIIRTLLMQPVQQQRNAEVKRRALWMVCTVLAVFIICFVPHHVVQLPWTLAELGFQDSKFHQAINDAHQVTLCLLSTNCVLDPVIYCFLTKKFRKHLTEKFYSMRSSRKCSRATTDTVTEVVVPFNQIPGNSLKN
  
Inhibitor
Name:
BDBM50282041
Synonyms:
1-{4-[5-(3,4-Dimethoxy-phenyl)-tetrahydro-furan-2-yloxymethyl]-phenyl}-2-methyl-1H-benzoimidazole | CHEMBL37602
Type:
Small organic molecule
Emp. Form.:
C27H28N2O4
Mol. Mass.:
444.5222
SMILES:
COc1ccc(cc1OC)C1CCC(OCc2ccc(cc2)-n2c(C)nc3ccccc23)O1
Structure:
Search PDB for entries with ligand similarity: